Immuneel Therapeutics
↗Bengaluru, India
Immuneel Therapeutics is a clinical-stage biotechnology company focused on making advanced cell and gene therapies, specifically CAR-T cell therapies, affordable and accessible in India and emerging markets. Founded by global healthcare leaders including Kiran Mazumdar-Shaw and Siddhartha Mukherjee, the company operates a state-of-the-art cGMP manufacturing facility in Bengaluru.
The company achieved a major milestone in early 2025 by receiving regulatory approval from India's CDSCO for its lead CAR-T product, Qartemi, for the treatment of B-cell malignancies. Immuneel is pioneering a decentralized manufacturing model and leveraging global partnerships to reduce the cost of these life-saving treatments by up to 80% compared to Western prices.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Cell & Gene Therapy (Oncology)
SIZE & FINANCIALS
Employees:51-200
Revenue:<$1M (Pre-commercial/Early Launch)
Founded:2018
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$39.3M
Investors:Eight Roads Ventures, F-Prime Capital, True North Fund, Khosla Ventures, Syngene International, Kotak Mahindra Bank
PIPELINE
Stage:Commercial
Lead Drug Stage:Approved (India)
Modalities:Cell therapy, CAR-T, Gene therapy
Active Trials:2
Trial Phases:Phase 1: 1 | Phase 2: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Hospital Clinic de Barcelona (Licensing for IMN-003A), ScaleReady (G-Rex manufacturing platform), Applied Cells (MARS Atlas platform collaboration), Narayana Health (Clinical and manufacturing site)
COMPETITION
Position:Leader (in the Indian CAR-T market)
Competitors:ImmunoACT (NexCAR19), Novartis (Kymriah), Gilead/Kite (Yescarta), Bristol Myers Squibb (Breyanzi)
LEADERSHIP
Key Executives:
Amit Mookim - CEO
Arun Anand - COO
Scientific Founders:Dr. Siddhartha Mukherjee, Dr. Kush Parmar, Kiran Mazumdar-Shaw
Board Members:Kiran Mazumdar-Shaw, Dr. Siddhartha Mukherjee, Dr. Kush Parmar
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Immuneel Therapeutics. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.